by Angus Liu
Cell & Gene Therapy
Catalent Cell and Gene Therapy is a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent’s experience in autologous and allogeneic cell therapy complements its industry-leading expertise and commercial success in gene therapy development, manufacturing, and adeno-associated virus (AAV) vector production. Its cell therapy offering includes expertise with a variety of cell types including chimeric antigen receptor T cells (CAR-T). With facilities in the US and Europe and continued new investments, Catalent is dedicated to supporting its customers and their patients. Catalent has produced more than 100 cGMP batches across 60+ clinical and commercial programs.